Marta Zalacain

29PUBLICATIONS
145CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMolecular targetsPacific Peoples social, cultural, emotional and spiritual wellbeingCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jul 16, 2026
Diverse origin and nature of tumor-infiltrating lymphocytes: the infection hypothesis.

|Feb 26, 2026
Feasibility and Safety of Autologous Dendritic Cell Vaccination Combined with Radio-Chemotherapy in Newly Diagnosed Glioblastoma: A Retrospective Single-Center Series.

Inés Esparragosa Vázquez, Ascensión López-Díaz de Cerio, Susana Inoges

|Jan 08, 2025
Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial.

Nicholas A Vitanza, Rebecca Ronsley, Michelle Choe

|Jul 27, 2024
Differential Impact of Valproic Acid on SLC5A8, SLC12A2, SLC12A5, CDH1, and CDH2 Expression in Adult Glioblastoma Cells.

Milda Juknevičienė, Ingrida Balnytė, Angelija Valančiūtė

|Mar 30, 2024
The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models.

Daniel de la Nava, Iker Ausejo-Mauleon, Virginia Laspidea

|Aug 16, 2023
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.

Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji

Pageof 5

Frequent Collaborators

7 joint publications

Candelaria Gomez-Manzano

6 joint publications

Juan Fueyo

6 joint publications

Marc Garcia-Moure

6 joint publications

Ana Patiño-García